Validity of the UK early access to medicines scheme criteria for Remdesivir use in patients with COVID-19 disease

File(s)

Validity of the UK Early Access to Medicines Scheme Criteria for Remdesivir use in patients with COVID-19 disease.pdf (1.11 MB)

Accepted version

Show more

Author(s)

Daunt, Anna

Perez-Guzman, Pablo N

Liew, Felicity

Hauck, Katharina

Costelloe, Ceire E

more

Type

Journal Article

Date Issued

2020-10-01

Date Acceptance

2020-06-19

Citation

Journal of Infection, 2020, 81 (4), pp.666-668

URI

http://hdl.handle.net/10044/1/87414

URL

https://www.sciencedirect.com/science/article/pii/S0163445320304308?via%3Dihub

DOI

https://www.dx.doi.org/10.1016/j.jinf.2020.06.049

ISSN

0163-4453

Publisher

British Infection Society

Start Page

666

End Page

668

Journal / Book Title

Journal of Infection

Volume

81

Issue

4

Copyright Statement

© Elsevier Ltd. All rights reserved. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence http://creativecommons.org/licenses/by-nc-nd/4.0/

License URL

http://creativecommons.org/licenses/by-nc-nd/4.0/

Sponsor

National Institute for Health Research

Medical Research Council (MRC)

National Institute for Health Research

Imperial College Healthcare NHS Trust: Research Capability Funding (RCF)

National Institute of Health and Medical Research

Identifier

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000574392800037&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Grant Number

RP-2016-07-012

MR/R015600/1

NIHR200908

RDF04

NIHR200180

Subjects

Science & Technology

Life Sciences & Biomedicine

Infectious Diseases

Publication Status

Published

Date Publish Online

2020-06-20